High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer

Eur J Cancer. 1994;30A(1):129-30. doi: 10.1016/s0959-8049(05)80037-1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Neoplasms / secondary*
  • Cell Division
  • Humans
  • Male
  • Ploidies
  • Prognosis
  • Prostatic Neoplasms / pathology*
  • Recurrence
  • Retrospective Studies